Binder Andrew, Ali Asghar, Chawla Raveen, Aziz Hammad A, Abbate Antonio, Jovin Ion S
a 1 Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Expert Rev Cardiovasc Ther. 2015;13(9):1045-57. doi: 10.1586/14779072.2015.1070669. Epub 2015 Jul 22.
Effective primary and secondary prevention and advances in cardiac surgery have significantly improved the care and outcomes of patients with myocardial ischemia. While timely reperfusion has proved to be an invaluable tool, ischemia-reperfusion injury represents a mechanism that may limit its effectiveness. Numerous experimental studies have shown effective protection from ischemia-reperfusion injury in animal models, but translation into clinical practice has been less successful. This article summarizes the role of ischemia-reperfusion injury in the pathophysiology of ischemic heart disease and gives an overview of the various modalities that have been developed in order to provide myocardial protection from reperfusion injury in clinical practice.
有效的一级和二级预防以及心脏外科手术的进展显著改善了心肌缺血患者的治疗和预后。虽然及时再灌注已被证明是一种非常有价值的手段,但缺血再灌注损伤是一种可能限制其有效性的机制。大量实验研究表明,在动物模型中可有效预防缺血再灌注损伤,但转化为临床实践的效果却不太理想。本文总结了缺血再灌注损伤在缺血性心脏病病理生理学中的作用,并概述了为在临床实践中提供心肌保护以防止再灌注损伤而开发的各种方法。